APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mitogen Activated Protein Kinase 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mitogen Activated Protein Kinase 1 Industry Growth and Trends Forecast to 2032

22 December 202598 pages

Choose your research edition.

Industry ResearchMitogen Activated Protein Kinase 1 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Mitogen Activated Protein Kinase 1 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Mitogen Activated Protein Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mitogen Activated Protein Kinase 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mitogen Activated Protein Kinase 1 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Mitogen Activated Protein Kinase 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mitogen Activated Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mitogen Activated Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mitogen Activated Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mitogen Activated Protein Kinase 1 include Merck & Co., Inc., Merck KGaA, Laurent Pharmaceuticals Inc., Kura Oncology, Inc., Genentech, Inc., Asana BioSciences, LLC, AGV Discovery, SAS and Aeterna Zentaris Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mitogen Activated Protein Kinase 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mitogen Activated Protein Kinase 1 market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mitogen Activated Protein Kinase 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mitogen Activated Protein Kinase 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mitogen Activated Protein Kinase 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mitogen Activated Protein Kinase 1 Market by Company

Merck & Co., Inc.

Merck KGaA

Laurent Pharmaceuticals Inc.

Kura Oncology, Inc.

Genentech, Inc.

Asana BioSciences, LLC

AGV Discovery, SAS

Aeterna Zentaris Inc.

Mitogen Activated Protein Kinase 1 Segment by Type

CB-745

JRP-890

KO-947

LY-3214996

Others

Mitogen Activated Protein Kinase 1 Segment by Application

Pancreatic Ductal Adenocarcinoma

Solid Tumor

Breast Cancer

Colon Cancer

Others

Mitogen Activated Protein Kinase 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mitogen Activated Protein Kinase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mitogen Activated Protein Kinase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mitogen Activated Protein Kinase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mitogen Activated Protein Kinase 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mitogen Activated Protein Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CB-745 Table 2. Major Company of JRP-890 Table 3. Major Company of KO-947 Table 4. Major Company of LY-3214996 Table 5. Major Company of Others Table 6. Global Mitogen Activated Protein Kinase 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (k units) Table 8. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Type (2021-2026) Table 11. Global Mitogen Activated Protein Kinase 1 Price by Type (2021-2026) & (US$/unit) Table 12. Global Mitogen Activated Protein Kinase 1 Sales by Type (2027-2032) & (k units) Table 13. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Mitogen Activated Protein Kinase 1 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Type (2027-2032) Table 16. Global Mitogen Activated Protein Kinase 1 Price by Type (2027-2032) & (US$/unit) Table 17. North America Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (k units) Table 18. North America Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (k units) Table 20. Europe Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (k units) Table 24. Latin America Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 27. Mitogen Activated Protein Kinase 1 Industry Trends Table 28. Mitogen Activated Protein Kinase 1 Industry Drivers Table 29. Mitogen Activated Protein Kinase 1 Industry Opportunities and Challenges Table 30. Mitogen Activated Protein Kinase 1 Industry Restraints Table 31. Global Mitogen Activated Protein Kinase 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Mitogen Activated Protein Kinase 1 Revenue Market Share by Company (2021-2026) Table 33. Global Mitogen Activated Protein Kinase 1 Sales by Company (2021-2026) & (k units) Table 34. Global Mitogen Activated Protein Kinase 1 Sales Share by Company (2021-2026) Table 35. Global Mitogen Activated Protein Kinase 1 Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Mitogen Activated Protein Kinase 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Mitogen Activated Protein Kinase 1 Major Company Production Sites and Headquarters Table 38. Global Mitogen Activated Protein Kinase 1 Company, Product Type & Application Table 39. Global Mitogen Activated Protein Kinase 1 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Mitogen Activated Protein Kinase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Mitogen Activated Protein Kinase 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Mitogen Activated Protein Kinase 1 Sales by Region (2021-2026) & (k units) Table 44. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Mitogen Activated Protein Kinase 1 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Region (2021-2026) Table 47. Global Mitogen Activated Protein Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Mitogen Activated Protein Kinase 1 Sales by Region (2027-2032) & (k units) Table 49. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Mitogen Activated Protein Kinase 1 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Region (2027-2032) Table 52. Global Mitogen Activated Protein Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Mitogen Activated Protein Kinase 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (k units) Table 55. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Application (2021-2026) Table 58. Global Mitogen Activated Protein Kinase 1 Price by Application (2021-2026) & (US$/unit) Table 59. Global Mitogen Activated Protein Kinase 1 Sales by Application (2027-2032) & (k units) Table 60. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Mitogen Activated Protein Kinase 1 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Application (2027-2032) Table 63. Global Mitogen Activated Protein Kinase 1 Price by Application (2027-2032) & (US$/unit) Table 64. North America Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (k units) Table 65. North America Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (k units) Table 67. Europe Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (k units) Table 71. Latin America Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 74. Merck & Co., Inc. Company Information Table 75. Merck & Co., Inc. Business Overview Table 76. Merck & Co., Inc. Mitogen Activated Protein Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck & Co., Inc. Mitogen Activated Protein Kinase 1 Product Portfolio Table 78. Merck & Co., Inc. Recent Development Table 79. Merck KGaA Company Information Table 80. Merck KGaA Business Overview Table 81. Merck KGaA Mitogen Activated Protein Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Merck KGaA Mitogen Activated Protein Kinase 1 Product Portfolio Table 83. Merck KGaA Recent Development Table 84. Laurent Pharmaceuticals Inc. Company Information Table 85. Laurent Pharmaceuticals Inc. Business Overview Table 86. Laurent Pharmaceuticals Inc. Mitogen Activated Protein Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Laurent Pharmaceuticals Inc. Mitogen Activated Protein Kinase 1 Product Portfolio Table 88. Laurent Pharmaceuticals Inc. Recent Development Table 89. Kura Oncology, Inc. Company Information Table 90. Kura Oncology, Inc. Business Overview Table 91. Kura Oncology, Inc. Mitogen Activated Protein Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Kura Oncology, Inc. Mitogen Activated Protein Kinase 1 Product Portfolio Table 93. Kura Oncology, Inc. Recent Development Table 94. Genentech, Inc. Company Information Table 95. Genentech, Inc. Business Overview Table 96. Genentech, Inc. Mitogen Activated Protein Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Genentech, Inc. Mitogen Activated Protein Kinase 1 Product Portfolio Table 98. Genentech, Inc. Recent Development Table 99. Asana BioSciences, LLC Company Information Table 100. Asana BioSciences, LLC Business Overview Table 101. Asana BioSciences, LLC Mitogen Activated Protein Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Asana BioSciences, LLC Mitogen Activated Protein Kinase 1 Product Portfolio Table 103. Asana BioSciences, LLC Recent Development Table 104. AGV Discovery, SAS Company Information Table 105. AGV Discovery, SAS Business Overview Table 106. AGV Discovery, SAS Mitogen Activated Protein Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. AGV Discovery, SAS Mitogen Activated Protein Kinase 1 Product Portfolio Table 108. AGV Discovery, SAS Recent Development Table 109. Aeterna Zentaris Inc. Company Information Table 110. Aeterna Zentaris Inc. Business Overview Table 111. Aeterna Zentaris Inc. Mitogen Activated Protein Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Aeterna Zentaris Inc. Mitogen Activated Protein Kinase 1 Product Portfolio Table 113. Aeterna Zentaris Inc. Recent Development Table 114. North America Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. North America Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (k units) Table 116. North America Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 117. North America Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 118. North America Mitogen Activated Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 119. North America Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Mitogen Activated Protein Kinase 1 Market Share by Country (2021-2026) Table 122. North America Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Mitogen Activated Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 124. Europe Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Europe Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (k units) Table 126. Europe Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 127. Europe Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 128. Europe Mitogen Activated Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Mitogen Activated Protein Kinase 1 Market Share by Country (2021-2026) Table 132. Europe Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Mitogen Activated Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (k units) Table 136. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 138. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Mitogen Activated Protein Kinase 1 Market Share by Country (2021-2026) Table 142. Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Mitogen Activated Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 144. Latin America Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Latin America Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (k units) Table 146. Latin America Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 147. Latin America Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 148. Latin America Mitogen Activated Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Mitogen Activated Protein Kinase 1 Market Share by Country (2021-2026) Table 152. Latin America Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Mitogen Activated Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (k units) Table 156. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 158. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Mitogen Activated Protein Kinase 1 Market Share by Country (2021-2026) Table 162. Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Mitogen Activated Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Mitogen Activated Protein Kinase 1 Distributors List Table 167. Mitogen Activated Protein Kinase 1 Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Mitogen Activated Protein Kinase 1 Image Figure 2. Global Mitogen Activated Protein Kinase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mitogen Activated Protein Kinase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Mitogen Activated Protein Kinase 1 Sales (2021-2032) & (k units) Figure 5. CB-745 Image Figure 6. Global CB-745 Sales YoY Growth (2021-2032) & (k units) Figure 7. JRP-890 Image Figure 8. Global JRP-890 Sales YoY Growth (2021-2032) & (k units) Figure 9. KO-947 Image Figure 10. Global KO-947 Sales YoY Growth (2021-2032) & (k units) Figure 11. LY-3214996 Image Figure 12. Global LY-3214996 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Mitogen Activated Protein Kinase 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Mitogen Activated Protein Kinase 1 Market Share by Type 2025 VS 2032 Figure 17. North America Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 18. North America Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 19. Europe Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Mitogen Activated Protein Kinase 1 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Pancreatic Ductal Adenocarcinoma Image Figure 30. Global Pancreatic Ductal Adenocarcinoma Sales YoY Growth (2021-2032) & (k units) Figure 31. Solid Tumor Image Figure 32. Global Solid Tumor Sales YoY Growth (2021-2032) & (k units) Figure 33. Breast Cancer Image Figure 34. Global Breast Cancer Sales YoY Growth (2021-2032) & (k units) Figure 35. Colon Cancer Image Figure 36. Global Colon Cancer Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Mitogen Activated Protein Kinase 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Mitogen Activated Protein Kinase 1 Market Share by Application 2025 VS 2032 Figure 41. North America Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 42. North America Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 43. Europe Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 44. Europe Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 47. Latin America Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 51. North America Mitogen Activated Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Mitogen Activated Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Mitogen Activated Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Mitogen Activated Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Mitogen Activated Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Mitogen Activated Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Mitogen Activated Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Mitogen Activated Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Mitogen Activated Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Mitogen Activated Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Mitogen Activated Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Mitogen Activated Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Mitogen Activated Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Mitogen Activated Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Mitogen Activated Protein Kinase 1 Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Mitogen Activated Protein Kinase 1 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • CB-745
  • JRP-890
  • KO-947
  • LY-3214996
  • Others
Applications
  • Pancreatic Ductal Adenocarcinoma
  • Solid Tumor
  • Breast Cancer
  • Colon Cancer
  • Others
Companies covered
  • Merck & Co., Inc.
  • Merck KGaA
  • Laurent Pharmaceuticals Inc.
  • Kura Oncology, Inc.
  • Genentech, Inc.
  • Asana BioSciences, LLC
  • AGV Discovery, SAS
  • Aeterna Zentaris Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mitogen Activated Protein Kinase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mitogen Activated Protein Kinase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mitogen Activated Protein Kinase 1 Market by Type
  6. 1.3.1 CB-745
  7. 1.3.2 JRP-890
  8. 1.3.3 KO-947
  9. 1.3.4 LY-3214996
  10. 1.3.5 Others
  11. 1.4 Global Mitogen Activated Protein Kinase 1 Market Size by Type
  12. 1.4.1 Global Mitogen Activated Protein Kinase 1 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Mitogen Activated Protein Kinase 1 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Mitogen Activated Protein Kinase 1 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Mitogen Activated Protein Kinase 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Mitogen Activated Protein Kinase 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Mitogen Activated Protein Kinase 1 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mitogen Activated Protein Kinase 1 Industry Trends
  2. 2.2 Mitogen Activated Protein Kinase 1 Industry Drivers
  3. 2.3 Mitogen Activated Protein Kinase 1 Industry Opportunities and Challenges
  4. 2.4 Mitogen Activated Protein Kinase 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mitogen Activated Protein Kinase 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Mitogen Activated Protein Kinase 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Mitogen Activated Protein Kinase 1 Price (2021-2026)
  4. 3.4 Global Mitogen Activated Protein Kinase 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mitogen Activated Protein Kinase 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Mitogen Activated Protein Kinase 1 Company, Product Type & Application
  7. 3.7 Global Mitogen Activated Protein Kinase 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mitogen Activated Protein Kinase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mitogen Activated Protein Kinase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mitogen Activated Protein Kinase 1 Tier 1, Tier 2, and Tier 3
4 Mitogen Activated Protein Kinase 1 Regional Status and Outlook
  1. 4.1 Global Mitogen Activated Protein Kinase 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mitogen Activated Protein Kinase 1 Historic Market Size by Region
  3. 4.2.1 Global Mitogen Activated Protein Kinase 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mitogen Activated Protein Kinase 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mitogen Activated Protein Kinase 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mitogen Activated Protein Kinase 1 Forecasted Market Size by Region
  7. 4.3.1 Global Mitogen Activated Protein Kinase 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mitogen Activated Protein Kinase 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mitogen Activated Protein Kinase 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mitogen Activated Protein Kinase 1 by Application
  1. 5.1 Mitogen Activated Protein Kinase 1 Market by Application
  2. 5.1.1 Pancreatic Ductal Adenocarcinoma
  3. 5.1.2 Solid Tumor
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Colon Cancer
  6. 5.1.5 Others
  7. 5.2 Global Mitogen Activated Protein Kinase 1 Market Size by Application
  8. 5.2.1 Global Mitogen Activated Protein Kinase 1 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Mitogen Activated Protein Kinase 1 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Mitogen Activated Protein Kinase 1 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Mitogen Activated Protein Kinase 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Mitogen Activated Protein Kinase 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Mitogen Activated Protein Kinase 1 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck & Co., Inc.
  2. 6.1.1 Merck & Co., Inc. Company Information
  3. 6.1.2 Merck & Co., Inc. Business Overview
  4. 6.1.3 Merck & Co., Inc. Mitogen Activated Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co., Inc. Mitogen Activated Protein Kinase 1 Product Portfolio
  6. 6.1.5 Merck & Co., Inc. Recent Developments
  7. 6.2 Merck KGaA
  8. 6.2.1 Merck KGaA Company Information
  9. 6.2.2 Merck KGaA Business Overview
  10. 6.2.3 Merck KGaA Mitogen Activated Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck KGaA Mitogen Activated Protein Kinase 1 Product Portfolio
  12. 6.2.5 Merck KGaA Recent Developments
  13. 6.3 Laurent Pharmaceuticals Inc.
  14. 6.3.1 Laurent Pharmaceuticals Inc. Company Information
  15. 6.3.2 Laurent Pharmaceuticals Inc. Business Overview
  16. 6.3.3 Laurent Pharmaceuticals Inc. Mitogen Activated Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Laurent Pharmaceuticals Inc. Mitogen Activated Protein Kinase 1 Product Portfolio
  18. 6.3.5 Laurent Pharmaceuticals Inc. Recent Developments
  19. 6.4 Kura Oncology, Inc.
  20. 6.4.1 Kura Oncology, Inc. Company Information
  21. 6.4.2 Kura Oncology, Inc. Business Overview
  22. 6.4.3 Kura Oncology, Inc. Mitogen Activated Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kura Oncology, Inc. Mitogen Activated Protein Kinase 1 Product Portfolio
  24. 6.4.5 Kura Oncology, Inc. Recent Developments
  25. 6.5 Genentech, Inc.
  26. 6.5.1 Genentech, Inc. Company Information
  27. 6.5.2 Genentech, Inc. Business Overview
  28. 6.5.3 Genentech, Inc. Mitogen Activated Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Genentech, Inc. Mitogen Activated Protein Kinase 1 Product Portfolio
  30. 6.5.5 Genentech, Inc. Recent Developments
  31. 6.6 Asana BioSciences, LLC
  32. 6.6.1 Asana BioSciences, LLC Company Information
  33. 6.6.2 Asana BioSciences, LLC Business Overview
  34. 6.6.3 Asana BioSciences, LLC Mitogen Activated Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Asana BioSciences, LLC Mitogen Activated Protein Kinase 1 Product Portfolio
  36. 6.6.5 Asana BioSciences, LLC Recent Developments
  37. 6.7 AGV Discovery, SAS
  38. 6.7.1 AGV Discovery, SAS Company Information
  39. 6.7.2 AGV Discovery, SAS Business Overview
  40. 6.7.3 AGV Discovery, SAS Mitogen Activated Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AGV Discovery, SAS Mitogen Activated Protein Kinase 1 Product Portfolio
  42. 6.7.5 AGV Discovery, SAS Recent Developments
  43. 6.8 Aeterna Zentaris Inc.
  44. 6.8.1 Aeterna Zentaris Inc. Company Information
  45. 6.8.2 Aeterna Zentaris Inc. Business Overview
  46. 6.8.3 Aeterna Zentaris Inc. Mitogen Activated Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aeterna Zentaris Inc. Mitogen Activated Protein Kinase 1 Product Portfolio
  48. 6.8.5 Aeterna Zentaris Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Mitogen Activated Protein Kinase 1 Sales by Country
  2. 7.1.1 North America Mitogen Activated Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mitogen Activated Protein Kinase 1 Market Size by Country
  6. 7.2.1 North America Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mitogen Activated Protein Kinase 1 Sales by Country
  2. 8.1.1 Europe Mitogen Activated Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mitogen Activated Protein Kinase 1 Market Size by Country
  6. 8.2.1 Europe Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Country
  2. 9.1.1 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mitogen Activated Protein Kinase 1 Sales by Country
  2. 10.1.1 South America Mitogen Activated Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mitogen Activated Protein Kinase 1 Market Size by Country
  6. 10.2.1 South America Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mitogen Activated Protein Kinase 1 Sales by Country
  2. 11.1.1 Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mitogen Activated Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mitogen Activated Protein Kinase 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mitogen Activated Protein Kinase 1 Value Chain Analysis
  2. 12.1.1 Mitogen Activated Protein Kinase 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mitogen Activated Protein Kinase 1 Production Mode & Process
  7. 12.2 Mitogen Activated Protein Kinase 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mitogen Activated Protein Kinase 1 Distributors
  10. 12.2.3 Mitogen Activated Protein Kinase 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst